0001179110-17-009109.txt : 20170615 0001179110-17-009109.hdr.sgml : 20170615 20170615164336 ACCESSION NUMBER: 0001179110-17-009109 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170613 FILED AS OF DATE: 20170615 DATE AS OF CHANGE: 20170615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DEPOMED INC CENTRAL INDEX KEY: 0001005201 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943229046 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7999 GATEWAY BLVD. STREET 2: SUITE 300 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-744-8000 MAIL ADDRESS: STREET 1: 7999 GATEWAY BLVD. STREET 2: SUITE 300 CITY: NEWARK STATE: CA ZIP: 94560 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vargas Thadd M CENTRAL INDEX KEY: 0001529033 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13111 FILM NUMBER: 17913943 MAIL ADDRESS: STREET 1: 1360 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 edgar.xml FORM 4 - X0306 4 2017-06-13 0 0001005201 DEPOMED INC DEPO 0001529033 Vargas Thadd M C/O DEPOMED, INC. 7999 GATEWAY BOULEVARD, SUITE 300 NEWARK CA 94560 0 1 0 0 SVP, Business Development Common Stock 2017-06-13 4 S 0 21751 9.587 D 19816 D Common Stock 2017-06-13 4 S 0 19816 9.60 D 0 D Common Stock 2017-06-13 4 M 0 19320 7.12 A 19320 D Common Stock 2017-06-13 4 M 0 45000 6.08 A 64320 D Common Stock 2017-06-13 4 M 0 43000 6.11 A 107320 D Common Stock 2017-06-13 4 M 0 53500 6.77 A 160820 D Common Stock 2017-06-13 4 S 0 160820 9.526 D 0 D Common Stock 7.12 2017-06-13 4 M 0 19320 0 D 2021-01-14 Common Stock 19320 0 D Common Stock 6.08 2017-06-13 4 M 0 45000 0 D 2021-09-01 Common Stock 45000 0 D Common Stock 6.11 2017-06-13 4 M 0 43000 0 D 2022-01-12 Common Stock 43000 0 D Common Stock 6.77 2017-06-13 4 M 0 53500 0 D 2023-02-07 Common Stock 53500 0 D Amount does not include any unvested restricted stock previously reported on Form 4 by the reporting person. The price reported is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares at each price within the range set forth in this footnote. 19,320 stock options were granted on January 14, 2011 and were exercisable in 48 equal monthly installments. 45,000 stock options were granted on September 1, 2011 and were exercisable in 48 equal monthly installments. 43,000 stock options were granted on January 12, 2012 and were exercisable in 48 equal monthly installments. 53,500 stock options were granted on February 7, 2013 and were exercisable in 48 equal monthly installments. /s/ Thadd M. Vargas 2017-06-14